Abstract
Sebaceous carcinoma of the eyelid is a relatively rare entity. A 70 year old woman presented with a left lower eyelid swelling growing over the last year. Upon examination, the external two thirds of the tarsal edge were swollen, inflamed, and bleeding on palpation. The pathological examination was in favor of a sebaceous carcinoma. The patient underwent a surgical excision and the outcome was satisfactory. The palpebral sebaceous carcinoma is variable and can mimic various benign conditions, explaining the frequent diagnostic delays. The treatment is surgical. It consists of a complete resection of the lesion associated with wide safety margins. Only an early diagnosis associated with a large surgical excision improves the prognosis.
Highlights
Sebaceous carcinoma of the eyelid is a relatively rare entity
We report the case of a patient with an inferior palpebral sebaceous carcinoma who underwent successful surgical excision
A 70 year old woman, with no medical history, presented to the outpatient clinic with a chief complaint of a left lower eyelid swelling growing over the last year (Fig. 1)
Summary
Sebaceous carcinoma of the eyelid is a relatively rare entity. Tumoral proliferation of the eyelid’s sebaceous glands, it mimics several clinical presentations. We report the case of a patient with an inferior palpebral sebaceous carcinoma who underwent successful surgical excision. A 70 year old woman, with no medical history, presented to the outpatient clinic with a chief complaint of a left lower eyelid swelling growing over the last year (Fig. 1). No clinical extension to the orbit, nor cervical lymph nodes, were noted. The pathological examination was in favor of a sebaceous carcinoma, and the CT scan showed a 4 millimeters enlargement of the left lower eyelid with no orbital extension. The patient underwent a surgical excision of the carcinoma with 5 millimeters margins (Fig. 2). A three month follow up showed a well healed eyelid with minimal lagophthalmos and no sign of recurrence (Fig. 3)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
